Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

VG161 / ViroGin Biotech

NCT06126510: Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma

Recruiting

RoW

Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell), VG161

CNBG-Virogin Biotech (Shanghai) Ltd.

Sarcoma

07/25

01/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites